TGFB1 and breast carcinoma: Taken together, our findings identify a novel convergence point in MECs that enables β3 integrins to override the tumor suppressing activities of TGF-β, suggesting that integrin interdiction strategies may one day represent an innovative approach to re-establishing TGF-β mediated tumor suppression in progressing human breast cancers.